Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Intravenous formulations of neurokinin-1 antagonists

Intravenous formulations of neurokinin-1 antagonists

US Patent 9101615 · Granted Aug 11, 2015

Estimated economic value: $51,569,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified release gamma-hydroxybutyrate formulations having improved pharmacokine2025
Systems and methods of encoding BNPL transactions for terminal devices2025
Accelerometer contact microphones and methods thereof2023
Application curation2023
Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods2023
Methods of administering gamma hydroxybutyrate formulations after a high-fat mea2023
Mobility of user applications across cloud infrastructures2022
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,22021
(S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,22021
Paclitaxel pharmaceutical composition and pharmaceutical preparation thereof, pr2021
Application curation2021
(S)-N-(3-6-isopropoxypyridin-3-3YL)-1H-indazol-5-yl)-1-(2-(4-4(1-methyl-1H-1,2,42020